bromodeoxyuridine has been researched along with T-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botvinnik, A; Britan-Rosich, E; Climent, N; Kotler, M; Manevitch, Z; Moshel, O; Oliva, H; Olshevsky, U; Sharma, G; Shivam, P; Smith, Y | 1 |
| Alvey, JD; Bleavins, MR; Brott, DA; de la Iglesia, FA; Lalwani, ND | 1 |
2 other study(ies) available for bromodeoxyuridine and T-Cell Lymphoma
| Article | Year |
|---|---|
APOBEC3G rescues cells from the deleterious effects of DNA damage.
Topics: APOBEC-3G Deaminase; Bromodeoxyuridine; DNA Damage; DNA Repair; Humans; Lymphoma, T-Cell; Skin Neoplasms; Tumor Cells, Cultured; Ultraviolet Rays | 2021 |
Cell cycle dependent distribution of proliferating cell nuclear antigen/cyclin and cdc2-kinase in mouse T-lymphoma cells.
Topics: Animals; Antigens, Neoplasm; Bromodeoxyuridine; CDC2 Protein Kinase; Cell Cycle; Cell Division; Lymphoma, T-Cell; Mice; Mitosis; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Tumor Cells, Cultured | 1993 |